Nuoncology Labs Inc
OTC:NLAB
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
US |
N
|
Nuoncology Labs Inc
OTC:NLAB
|
29.3B USD | 0 | |
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
486.5B CAD | 1 854 047.2 | |
US |
G
|
Gould Investors LP
OTC:GDVTZ
|
334.2B USD | 0 | |
US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | -822 614 | |
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
78.8B Zac | 0 | |
US |
Music Licensing Inc
OTC:SONG
|
64.3B USD | 1 296.4 | ||
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
902.9T IDR | 0 | ||
US |
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | ||
US |
Ergo Science Corp
OTC:ERGN
|
55.2B USD | 3 185.8 | ||
US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | -18 316.7 | |
US |
G
|
GE Vernova LLC
NYSE:GEV
|
48.2B USD | 0 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.